Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2013 (Vol. 33, No. 14)

SIGnAL

URL:signal.salk.edu
  • Plenty of resources
  • Not the best site organization

Though not apparent from its name, the Salk Institute Genomic Analysis Laboratory (SIGnAL) is an oasis for Arabidopsis research. With a number of past and active research projects represented on the website, the SIGnAL site can be a tad difficult to navigate—or at the very least, a bit overwhelming. Fortunately, visitors to the site are helped out by the site map, which nicely organizes the site’s contents into seven major categories: databases and applications, datasets, T-DNA, T-DNA genotyping, microarray, FL-cDNA, and “about us.” Within these categories, visitors will find a plethora of resources and tools, such as a CREB target database, Arabidopsis transcriptome datasets, and links to some Arabidopsis and plant biology educational websites. Finally, so as to not slight the nonplant biologists out there, the website also contains links to a few human and mouse epigenetics databases.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »